Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
Read More Pharma Industry News Bristol Myers Squibb’s subcutaneous nivolumab shows promise in Phase 3 RCC trial Bristol Myers Squibb (NYSE: BMY) has announced results from its Phase 3 CheckMate -67T trial, which could revolutionize… byPallavi MadhirajuJanuary 29, 2024